Meldonium: Wada announces partial amnesty on substance which led to Maria Sharapova positive test

The women's tennis player was the most high-profile athlete to test positive for the substance this year

Mark Critchley
Wednesday 13 April 2016 12:23 BST
Comments
Sharapova announced on March 7 that she had tested positive for taking the drug
Sharapova announced on March 7 that she had tested positive for taking the drug (Getty Images)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Athletes who tested positive for the banned drug meldonium may be able to have their bans reversed, the World Anti-Doping Agency (Wada) has announced.

The anti-doping foundation has admitted that further research needs to be carried out to establish how long meldonium remains in the blood stream.

As a result, samples from tests conducted before March 1 2016 and which contain less than one microgram of meldonium may be seen as permissible.

“If the anti-doping organization finds that the athlete could not reasonably have known or suspected that the substance would still be present in his/her body on or after 1 January 2016, then a finding of no fault or negligence may be made,” a statement by the foundation reads.

“In the case of meldonium, there is currently a lack of clear scientific information on excretion times,” the statement adds.

“For this reason, a hearing panel might justifiably find… that an athlete who has established, on the balance of probabilities, that he or she ingested meldonium before 1 January 2016, could not reasonably have known or suspected the meldonium would still be present in his or her body on or after 1 January 2016.

“In these circumstances, WADA considers there may be grounds for no fault or negligence on the part of the athlete,” the statement continued.

The decision may have repercussions for women’s tennis player Maria Sharapova, who failed a test for meldonium while competing at the Australian Open in January.

The Russian was the most high-profile name to fall foul of anti-doping testers, as around 127 athletes worldwide were banned for use of the drug.

Meldonium, also known as mildronate, was added to Wada’s list of banned substances on January 1, with athletes being notified of its prohibition in the autumn of last year.

"The Russian Sports Ministry supports and welcomes the decision made by Wada because it has showed a willingness to understand the situation, rather than stick to the rulebook," said Russian sports minister Vitaly Mutko.

Mutko recently revealed that around 40 of his country’s athletes had failed tests for meldonium.

"They were ready to study how long it would take for meldonium to be eliminated from the body of an athlete,” he added. “WADA has demonstrated impartiality and being objective in the fight against doping."

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in